David Kirske

Insider Reports History

Location
Boston, MA
Signature
/s/ David Kirske
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Kirske:

Company Role Class Num Shares Value Price $ Report Date Ownership
X4 Pharmaceuticals, Inc Chief Financial Officer Common Stock 193,254 $757,555 $3.92 14 Aug 2025 Direct
X4 Pharmaceuticals, Inc Chief Financial Officer Stock Option (right to buy) 1,552,769 29 Oct 2025 Direct
CTI BIOPHARMA CORP EVP, Chief Financial Officer Common Stock 0 $9.10 26 Jun 2023 Direct
CTI BIOPHARMA CORP EVP, Chief Financial Officer Stock Option (Right to Buy) 0 26 Jun 2023 Direct

Insider Reports Filed by David Kirske

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XFOR X4 Pharmaceuticals, Inc 29 Oct 2025 1 $0 4 Chief Financial Officer 31 Oct 2025, 16:41
XFOR X4 Pharmaceuticals, Inc 12 Aug 2025 0 $0 3 Chief Financial Officer 14 Aug 2025, 20:31
XFOR X4 Pharmaceuticals, Inc 12 Aug 2025 3 $0 4 Chief Financial Officer 14 Aug 2025, 20:31
/report/000089924323016485-kirske-david-2023-06-26 CTI BIOPHARMA CORP 26 Jun 2023 9 -$159,678 4 EVP, Chief Financial Officer 26 Jun 2023, 16:05
/report/000089924323008752-kirske-david-2023-03-14 CTI BIOPHARMA CORP 14 Mar 2023 1 $0 4 EVP, Chief Financial Officer 16 Mar 2023, 17:52
/report/000089129323000001-kirske-david-2022-12-29 CTI BIOPHARMA CORP 29 Dec 2022 16 -$272,190 4 EVP, Chief Financial Officer 03 Jan 2023, 17:36
/report/000089129322000047-kirske-david-2022-10-04 CTI BIOPHARMA CORP 04 Oct 2022 9 -$11,193 4 EVP, Chief Financial Officer 06 Oct 2022, 16:20
/report/000089129322000046-kirske-david-2022-09-29 CTI BIOPHARMA CORP 29 Sep 2022 12 -$718,991 4 EVP, Chief Financial Officer 03 Oct 2022, 18:26
/report/000089129322000045-kirske-david-2022-06-30 CTI BIOPHARMA CORP 30 Jun 2022 4 -$94,426 4 EVP, Chief Financial Officer 20 Sep 2022, 16:59
/report/000089129322000033-kirske-david-2022-06-17 CTI BIOPHARMA CORP 17 Jun 2022 6 -$197,505 4 EVP, Chief Financial Officer 17 Jun 2022, 16:57
/report/000089129322000032-kirske-david-2022-06-14 CTI BIOPHARMA CORP 14 Jun 2022 3 -$45,511 4 EVP, Chief Financial Officer 16 Jun 2022, 16:19
/report/000089924322010771-kirske-david-2021-06-30 CTI BIOPHARMA CORP 30 Jun 2021 3 +$7,617 4 EVP, Chief Financial Officer 11 Mar 2022, 18:41